Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1997 2
2000 1
2003 2
2006 1
2010 1
2011 1
2012 2
2013 2
2018 2
2019 2
2020 7
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641-649.
Wu JJ, Hansen JB, Patel DS, Nyholm N, Veverka KA, Swensen AR. Wu JJ, et al. Among authors: veverka ka. J Med Econ. 2020 Dec;23(12):1501-1502. doi: 10.1080/13696998.2020.1835857. Epub 2020 Nov 6. J Med Econ. 2020. PMID: 33040632 No abstract available.
Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis.
Wu JJ, Hansen JB, Patel DS, Nyholm N, Veverka KA, Swensen AR. Wu JJ, et al. Among authors: veverka ka. J Med Econ. 2020 Jun;23(6):641-649. doi: 10.1080/13696998.2020.1722139. Epub 2020 Mar 2. J Med Econ. 2020. PMID: 31985301
24 results